{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:02:02Z","timestamp":1775250122175,"version":"3.50.1"},"reference-count":57,"publisher":"Informa UK Limited","issue":"15","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.2217\/imt-2022-0049","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T08:19:35Z","timestamp":1693815575000},"page":"1257-1273","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8608-4660","authenticated-orcid":false,"given":"Vasiliki","family":"Siozopoulou","sequence":"first","affiliation":[{"name":"Department of Pathology, Antwerp University Hospital, Edegem, 2650, Belgium"},{"name":"Center for Oncological Research, Integrated Personalized & Precision Oncology Network, University of Antwerp, Wilrijk, 2610, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Smits","sequence":"additional","affiliation":[{"name":"Center for Oncological Research, Integrated Personalized & Precision Oncology Network, University of Antwerp, Wilrijk, 2610, Belgium"},{"name":"Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Edegem, 2650, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Zwaenepoel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Antwerp University Hospital, Edegem, 2650, Belgium"},{"name":"Center for Oncological Research, Integrated Personalized & Precision Oncology Network, University of Antwerp, Wilrijk, 2610, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Antwerp University Hospital, Edegem, 2650, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Pouliakis","sequence":"additional","affiliation":[{"name":"Second\u00a0Department of Pathology, National & Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, Athens, 12464, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick A","family":"Pauwels","sequence":"additional","affiliation":[{"name":"Department of Pathology, Antwerp University Hospital, Edegem, 2650, Belgium"},{"name":"Center for Oncological Research, Integrated Personalized & Precision Oncology Network, University of Antwerp, Wilrijk, 2610, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly","family":"Marcq","sequence":"additional","affiliation":[{"name":"Center for Oncological Research, Integrated Personalized & Precision Oncology Network, University of Antwerp, Wilrijk, 2610, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332"},{"key":"e_1_3_6_4_1","first-page":"3","volume-title":"Soft Tissue and Bone Tumours (5th edition).","author":"Who Classification of Tumours Editorial Board","year":"2020","unstructured":"Who Classification of Tumours Editorial Board . WHO Classification of Tumours. Soft Tissue and Bone Tumours (5th edition).IARC Publications, Lyon, France, 3 (2020)."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21605"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-016-0060-4"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-016-0047-1"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000487511"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.101590"},{"key":"e_1_3_6_10_1","unstructured":"National Cancer Institute\n. Types of cancer treatment. www.cancer.gov\/about-cancer\/treatment\/types\/immunotherapy"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30413-9"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2017-204853"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.02.79"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00774.x"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2015.07.007"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000446569"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2791"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3880"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0613"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31912"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0513-6"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-416"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2130"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.11.6752"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2012.689405"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm934"},{"issue":"1","key":"e_1_3_6_29_1","first-page":"1","article-title":"Trial watch: IDO inhibitors in cancer therapy","volume":"9","author":"Le Naour J","year":"2020","unstructured":"Le Naour J , GalluzziL , ZitvogelL , KroemerG , VacchelliE. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology9(1), 1\u201316 (2020).","journal-title":"Oncoimmunology"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130066"},{"issue":"11","key":"e_1_3_6_31_1","doi-asserted-by":"crossref","first-page":"e0143435","DOI":"10.1371\/journal.pone.0143435","article-title":"IDO downregulation induces sensitivity to pemetrexed, gemcitabine, FK866, and methoxyamine in human cancer cells","volume":"10","author":"Maleki Vareki S","year":"2015","unstructured":"Maleki Vareki S , ChenD , DiCresce Cet.al IDO downregulation induces sensitivity to pemetrexed, gemcitabine, FK866, and methoxyamine in human cancer cells. PLOS ONE10(11), e0143435; 1\u201322 (2015).","journal-title":"PLOS ONE"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1916"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020360"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1372"},{"key":"e_1_3_6_35_1","unstructured":"US FDA\n. FDA grants accelerated approval to pembrolizumab for first tissue\/site agnostic indication. www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-pembrolizumab-first-tissuesite-agnostic-indication"},{"issue":"2","key":"e_1_3_6_36_1","first-page":"107","article-title":"Expression of leukocyte common antigen (CD45) on various human leukemia\/lymphoma cell lines","volume":"40","author":"Nakano A","year":"1990","unstructured":"Nakano A , HaradaT , MorikawaS , KatoY. Expression of leukocyte common antigen (CD45) on various human leukemia\/lymphoma cell lines. Acta Pathol. Jpn40(2), 107\u2013115 (1990).","journal-title":"Acta Pathol. Jpn"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1261241"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.09.006"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010014"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30624-1"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00168"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.016"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2018.12.006"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040976"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6041"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02390-0"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01398"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222551"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.07.106"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2020.2124"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2017.529"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30006-8"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.04.004"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.036"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.11.005"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.1617"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30496-0"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.14377"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90187-8"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2022-0049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:05:42Z","timestamp":1715943942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2022-0049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.2217\/imt-2022-0049"],"URL":"https:\/\/doi.org\/10.2217\/imt-2022-0049","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}